# Precise Antiplatelet THerapy Guided by Platelet Aggregation Function in Ischemic STROKE（PATH-STROKE）

Study · id `cardio:ct-nct06269432` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06269432](<https://clinicaltrials.gov/study/NCT06269432>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT06269432

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1224 participants.

## Technical summary

Registry record NCT06269432. Randomized; single masking; primary purpose prevention. Start 2023-01-01 (actual); primary completion 2024-09-30 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose prevention
- Phase: Phase 4
- Enrolled: 1224 participants (enrolled count; ClinicalTrials.gov record NCT06269432, source copy `cardio:ctgov-nct06269432-2026-06-15`, retrieved 2026-10-26)
- Started: 2023-01-01 (actual) (ClinicalTrials.gov record NCT06269432, source copy `cardio:ctgov-nct06269432-2026-06-15`, retrieved 2026-10-26)
- Primary completion: 2024-09-30 (actual) (ClinicalTrials.gov record NCT06269432, source copy `cardio:ctgov-nct06269432-2026-06-15`, retrieved 2026-10-26)
- Completion: 2025-09-30 (actual) (ClinicalTrials.gov record NCT06269432, source copy `cardio:ctgov-nct06269432-2026-06-15`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT06269432, source copy `cardio:ctgov-nct06269432-2026-06-15`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06269432-2026-06-15`, retrieved 2026-10-26)

## The registry's words

- Brief title: Precise Antiplatelet THerapy Guided by Platelet Aggregation Function in Ischemic STROKE（PATH-STROKE）
- Acronym: PATH-STROKE
- Condition: Ischemic Stroke
- Condition: Antiplatelet Drug
- Intervention (Drug): Precision Antiplatelet Therapy Trial Group
- Intervention (Drug): Traditional Antiplatelet Therapy Control Group
- Lead sponsor: Sichuan Provincial People's Hospital
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: Sichuan Provincial People's Hospital (`cardio:org-sichuan-provincial-people-s-hospital`)

## Provenance

Content hash: d1ae49f0d0055fdb8bbe38ce2aa4b425ab1614621f2064753971b9dd85c9536f
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
